Publications
1. Alabousi M, Ghai S, Haider MA. MRI-guided Minimally Invasive Focal Therapies for Prostate Cancer. Radiology. 2023 Dec;309(3):e230431. doi: 10.1148/radiol.230431. PMID: 38051187. Review Senior Responsible Author
2. Abreu-Gomez J, Lim C, Haider MA. Contemporary Approach to Prostate Imaging and Data Reporting System Score 3 Lesions. Radiol Clin North Am. 2024 Jan;62(1):37-51. doi: 10.1016/j.rcl.2023.06.008. Epub 2023 Aug 21. PMID: 37973244. Review Senior Responsible Author
3. Klotz L, Chin J, Black PC, Finelli A, Anidjar M, Machado A, Levental M, Ghai S, Chang SD, Patel C, Kassam Z, Loblaw A, Kebabdjian M, Pond G, Haider MA. Magnetic Resonance Imaging-Targeted Versus Systematic Prostate Biopsies: 2-year Follow-up of a Prospective Randomized Trial (PRECISE). Eur Urol Oncol. 2023 Oct 12:S2588-9311(23)00204-3. doi: 10.1016/j.euo.2023.09.013. Epub ahead of print. PMID: 37838556. Senior Responsible Author
4. Qazi Arisar FA, Salinas-Miranda E, Ale Ali H, Lajkosz K, Chen C, Azhie A, Healy GM, Deniffel D, Haider MA, Bhat M. Development of a Radiomics-Based Model to Predict Graft Fibrosis in Liver Transplant Recipients: A Pilot Study. Transpl Int. 2023 Sep 1;36:11149. doi: 10.3389/ti.2023.11149. PMID: 37720416; PMCID: PMC10503435. Co-Senior Responsible Author
5. Fleming H, Dias AB, Talbot N, Li X, Corr K, Haider MA, Ghai S. Inter-reader variability and reproducibility of the PI-QUAL score in a multicentre setting. Eur J Radiol. 2023 Nov;168:111091. doi: 10.1016/j.ejrad.2023.111091. Epub 2023 Sep 9. PMID: 37717419.. Coauthor
6. Deniffel D, McAlpine K, Harder FN, Jain R, Lawson KA, Healy GM, Hui S, Zhang X, Salinas-Miranda E, van der Kwast T, Finelli A, Haider MA. Predicting the recurrence risk of renal cell carcinoma after nephrectomy: potential role of CT-radiomics for adjuvant treatment decisions. Eur Radiol. 2023 Aug;33(8):5840-5850. doi: 10.1007/s00330-023-09551-x. Epub 2023 Apr 19. PMID: 37074425. Senior Responsible Author
7. Liu X, Espin-Garcia O, Khalvati F, Namdar K, Fischer S, Haider MA, Jhaveri KS. Hepatocellular adenoma subtyping by qualitative MRI features and machine learning algorithm of integrated qualitative and quantitative features: a proof-of-concept study. Clin Radiol. 2023 Sep;78(9):679-686. doi: 10.1016/j.crad.2023.05.018. Epub 2023 Jun 10. PMID: 37365116.Coauthor
8. Basso Dias A, Mirshahvalad SA, Ortega C, Perlis N, Berlin A, van der Kwast T, Ghai S, Jhaveri K, Metser U, Haider M, Avery L, Veit-Haibach P. The role of [18F]-DCFPyL PET/MRI radiomics for pathological grade group prediction in prostate cancer. Eur J Nucl Med Mol Imaging. 2023 Jun;50(7):2167-2176. doi: 10.1007/s00259-023-06136-0. Epub 2023 Feb 21. PMID: 36809425. Coauthor
9. Harder FN, Heming CAM, Haider MA. mpMRI Interpretation in Active Surveillance for Prostate Cancer-An overview of the PRECISE score. Abdom Radiol (NY). 2023 Jul;48(7):2449-2455. doi: 10.1007/s00261-023-03912-2. Epub 2023 May 9. PMID: 37160473. Senior Responsible Author
10. Hinzpeter R, Kulanthaivelu R, Kohan A, Avery L, Pham NA, Ortega C, Metser U, Haider M, Veit-Haibach P. CT Radiomics and Whole Genome Sequencing in Patients with Pancreatic Ductal Adenocarcinoma: Predictive Radiogenomics Modeling. Cancers (Basel). 2022 Dec 16;14(24):6224. doi: 10.3390/cancers14246224. PMID: 36551709; PMCID: PMC9776865. Coauthor
11. Moore CM, King LE, Withington J, Amin MB, Andrews M, Briers E, Chen RC, Chinegwundoh FI, Cooperberg MR, Crowe J, Finelli A, Fitch MI, Frydenberg M, Giganti F, Haider MA, Freeman J, Gallo J, Gibbs S, Henry A, James N, Kinsella N, Lam TBL, Lichty M, Loeb S, Mahal BA, Mastris K, Mitra AV, Merriel SWD, van der Kwast T, Van Hemelrijck M, Palmer NR, Paterson CC, Roobol MJ, Segal P, Schraidt JA, Short CE, Siddiqui MM, Tempany CMC, Villers A, Wolinsky H, MacLennan S. Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer-A Report of a Movember International Consensus Meeting. Eur Urol Oncol. 2023 Apr;6(2):160-182. doi: 10.1016/j.euo.2023.01.003. Epub 2023 Jan 27. PMID: 36710133. Coauthor
12. White LM, Atinga A, Naraghi AM, Lajkosz K, Wunder JS, Ferguson P, Tsoi K, Griffin A, Haider M. T2-weighted MRI radiomics in high-grade intramedullary osteosarcoma: predictive accuracy in assessing histologic response to chemotherapy, overall survival, and disease-free survival. Skeletal Radiol. 2023 Mar;52(3):553-564. doi: 10.1007/s00256-022-04098-2. Epub 2022 Jul 1. PMID: 35778618. Senior Responsible Author
13. Liu X, Elbanan MG, Luna A, Haider MA, Smith AD, Sabottke CF, Spieler BM, Turkbey B, Fuentes D, Moawad A, Kamel S, Horvat N, Elsayes KM. Radiomics in Abdominopelvic Solid-Organ Oncologic Imaging: Current Status. AJR Am J Roentgenol. 2022 Dec;219(6):985-995. doi: 10.2214/AJR.22.27695. Epub 2022 Jun 29. PMID: 35766531. Coauthor
14. Nam R, Patel C, Milot L, Hird A, Wallis C, Macinnis P, Singh M, Emmenegger U, Sherman C, Haider MA. Prostate MRI versus PSA screening for prostate cancer detection (the MVP Study): a randomised clinical trial. BMJ Open. 2022 Nov 8;12(11):e059482. doi: 10.1136/bmjopen-2021-059482. PMID: 36351725. Senior Responsible Author
15. Salinas-Miranda E, Healy GM, Grünwald B, Jain R, Deniffel D, O'Kane GM, Grant R, Wilson J, Knox J, Gallinger S, Fischer S, Khokha R, Haider MA. Correlation of transcriptional subtypes with a validated CT radiomics score in resectable pancreatic ductal adenocarcinoma. Eur Radiol. 2022 Aug 25. doi: 10.1007/s00330-022-09057-y. Epub ahead of print. PMID: 36006427. Senior Responsible Author
16. Chang SD, Reinhold C, Kirkpatrick IDC, Clarke SE, Schieda N, Hurrell C, Cool DW, Tunis AS, Alabousi A, Diederichs BJ, Haider MA. Canadian Association of Radiologists Prostate MRI White Paper. Can Assoc Radiol J. 2022 Nov;73(4):626-638. doi: 10.1177/08465371221105532. Epub 2022 Aug 15. PMID: 35971326. Senior Responsible Author
17. Haider MA. It's Time for a Standardized MRI Assessment Scheme for Prostate Cancer Recurrence. Radiology. 2022 Aug;304(2):351-352. doi: 10.1148/radiol.220701. Epub 2022 May 10. PMID: 35536139. (Editorial) Senior Responsible Author
18. Turkbey B, Haider MA. Artificial Intelligence for Automated Cancer Detection on Prostate MRI: Opportunities and Ongoing Challenges, From the AJR Special Series on AI Applications. AJR Am J Roentgenol. 2022 Aug;219(2):188-194. doi: 10.2214/AJR.21.26917. Epub 2021 Dec 8. PMID: 34877870. (Editorial) Senior Responsible Author
19. Ghai S, Perlis N, Atallah C, Jokhu S, Corr K, Lajkosz K, Incze PF, Zlotta AR, Jain U, Fleming H, Finelli A, van der Kwast TH, Haider MA. Comparison of Micro-US and Multiparametric MRI for Prostate Cancer Detection in Biopsy-Naive Men. Radiology. 2022 Nov;305(2):390-398. doi: 10.1148/radiol.212163. Epub 2022 Jul 19. PMID: 35852425. Co-Senior Responsible Author
20. Corkum MT, Morton G, Loblaw DA, Tseng CL, Murgic J, Ravi A, Davidson MTM, Wronski M, Haider M, Chung HT. A Prospective Study of Magnetic Resonance Imaging-guided Focal Salvage High-dose-Rate Brachytherapy for Radiorecurrent Prostate Cancer: Updated Results of 30 Patients. Pract Radiat Oncol. 2022 Nov-Dec;12(6):e531-e537. doi: 10.1016/j.prro.2022.05.018. Epub 2022 Jun 17. PMID: 35718075.Coauthor
21. Perlis N, Finelli A, Lovas M, Lund A, Di Meo A, Lajkosz K, Berlin A, Papadakos J, Ghai S, Dennifel D, Meng E, Wiljer D, Alibhai S, Bakas V, Badzynski A, Lee O, Cafazzo J, Haider MA. Exploring the value of using patient-oriented MRI reports in clinical practice - a pilot study. Support Care Cancer. 2022 May 10. doi: 10.1007/s00520-022-07108-0. Epub ahead of print. PMID: 35534628. Senior Responsible Author
22. Deniffel D, Perlis N, Ghai S, Girgis S, Healy GM, Fleshner N, Hamilton R, Kulkarni G, Toi A, van der Kwast T, Zlotta A, Finelli A, Haider MA. Prostate biopsy in the era of MRI-targeting: towards a judicious use of additional systematic biopsy. Eur Radiol. 2022 Nov;32(11):7544-7554. doi: 10.1007/s00330-022-08822-3. Epub 2022 May 4. PMID: 35507051.. Senior Responsible Author
23. Healy GM, Salinas-Miranda E, Jain R, Dong X, Deniffel D, Borgida A, Hosni A, Ryan DT, Njeze N, McGuire A, Conlon KC, Dodd JD, Ryan ER, Grant RC, Gallinger S, Haider MA. Pre-operative radiomics model for prognostication in resectable pancreatic adenocarcinoma with external validation. Eur Radiol. 2022 Apr;32(4):2492-2505. doi: 10.1007/s00330-021-08314-w. Epub 2021 Nov 10. PMID: 34757450.Senior Responsible Author
24. Wong A, Gunraj H, Sivan V, Haider MA. Synthetic correlated diffusion imaging hyperintensity delineates clinically significant prostate cancer. Sci Rep. 2022 Dec;12(1):3376. Senior Author
25. Paxton M, Barbalat E, Perlis N, Menezes RJ, Gertner M, Dragas D, Haider MA, Finelli A, Trachtenberg J, Ghai S. Role of multiparametric MRI in long-term surveillance following focal laser ablation of prostate cancer. Br J Radiol. 2022 Mar 1;95(1131):20210414. doi: 10.1259/bjr.20210414. Epub 2021 Jul 29. PMID: 34324385. Coauthor
26. Haider MA, Brown J, Chin JLK, Perlis N, Schieda N, Loblaw A. Evidence-based guideline recommendations on multiparametric magnetic resonance imaging in the diagnosis of clinically significant prostate cancer: A Cancer Care Ontario updated clinical practice guideline. Can Urol Assoc J. 2022 Feb;16(2):16-23. doi: 10.5489/cuaj.7425. PMID: 35133265. First author
27. Kasivisvanathan V, Chan VW, Clement KD, Levis B, Haider M, Agarwal R, Emberton M, Pond GR, Takwoingi Y, Klotz L, Moore CM; VISION study collaborators. A protocol for the VISION study: An indiVidual patient data meta-analysis of randomised trials comparing MRI-targeted biopsy to standard transrectal ultraSound guided bIopsy in the detection of prOstate cancer. PLoS One. 2022 Feb 3;17(2):e0263345. doi: 10.1371/journal.pone.0263345. PMID: 35113918. Coauthor
28. Olivier J, Li W, Nieboer D, Helleman J, Roobol M, Gnanapragasam V, Frydenberg M, Sugimoto M, Carroll P, Morgan TM, Valdagni R, Rubio-Briones J, Robert G, Stricker P, Hayen A, Schoots I, Haider M, Moore CM, Denton B, Villers A; Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance GAP3 Consortium. Prostate Cancer Patients Under Active Surveillance with a Suspicious Magnetic Resonance Imaging Finding Are at Increased Risk of Needing Treatment: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium. Eur Urol Open Sci. 2022 Jan 3;35:59-67. doi: 10.1016/j.euros.2021.11.006. PMID: 35024633; PMCID: PMC8738894. Coauthor
29. Turkbey B, Haider MA. Deep learning-based artificial intelligence applications in prostate MRI: brief summary. Br J Radiol. 2021 Dec 3:20210563. doi: 10.1259/bjr.20210563. Epub ahead of print. PMID: 34860562. (Editorial) Senior Author
30. Haider MA, Brown J, Yao X, Chin J, Perlis N, Schieda N, Loblaw A. Multiparametric Magnetic Resonance Imaging in the Diagnosis of Clinically Significant Prostate Cancer: an Updated Systematic Review. Clin Oncol (R Coll Radiol). 2021 Dec;33(12):e599-e612. doi: 10.1016/j.clon.2021.07.016. Epub 2021 Aug 13. PMID: 34400038. First author (not a review paper, formal systematic review)
31. Namdar K, Haider MA, Khalvati F. A Modified AUC for Training Convolutional Neural Networks: Taking Confidence Into Account. Front Artif Intell. 2021;0:155. Coauthor
32. Penzkofer T, Padhani AR, Turkbey B, Haider MA, Huisman H, Walz J, Salomon G, Schoots IG, Richenberg J, Villeirs G, Panebianco V, Rouviere O, Logager VB, Barentsz J. ESUR/ESUI position paper: developing artificial intelligence for precision diagnosis of prostate cancer using magnetic resonance imaging. Eur Radiol. 2021 Dec;31(12):9567-9578. doi: 10.1007/s00330-021-08021-6. Epub 2021 May 15. PMID: 33991226; PMCID: PMC8589789. Coauthor (review/position paper)
33. Dayan I, Roth HR, Zhong A, Harouni A, Gentili A, Abidin AZ, Liu A, Costa AB, Wood BJ, Tsai CS, Wang CH, Hsu CN, Lee CK, Ruan P, Xu D, Wu D, Huang E, Kitamura FC, Lacey G, de Antônio Corradi GC, Nino G, Shin HH, Obinata H, Ren H, Crane JC, Tetreault J, Guan J, Garrett JW, Kaggie JD, Park JG, Dreyer K, Juluru K, Kersten K, Rockenbach MABC, Linguraru MG, Haider MA, AbdelMaseeh M, Rieke N, Damasceno PF, E Silva PMC, Wang P, Xu S, Kawano S, Sriswasdi S, Park SY, Grist TM, Buch V, Jantarabenjakul W, Wang W, Tak WY, Li X, Lin X, Kwon YJ, Quraini A, Feng A, Priest AN, Turkbey B, Glicksberg B, Bizzo B, Kim BS, Tor-Díez C, Lee CC, Hsu CJ, Lin C, Lai CL, Hess CP, Compas C, Bhatia D, Oermann EK, Leibovitz E, Sasaki H, Mori H, Yang I, Sohn JH, Murthy KNK, Fu LC, de Mendonça MRF, Fralick M, Kang MK, Adil M, Gangai N, Vateekul P, Elnajjar P, Hickman S, Majumdar S, McLeod SL, Reed S, Gräf S, Harmon S, Kodama T, Puthanakit T, Mazzulli T, de Lavor VL, Rakvongthai Y, Lee YR, Wen Y, Gilbert FJ, Flores MG, Li Q. Federated learning for predicting clinical outcomes in patients with COVID-19. Nat Med. 2021 Sep 15. doi: 10.1038/s41591-021-01506-3. Epub ahead of print. PMID: 34526699. Coauthor
34. Ghai S, Finelli A, Corr K, Chan R, Jokhu S, Li X, McCluskey S, Konukhova A, Hlasny E, van der Kwast TH, Incze PF, Zlotta AR, Hamilton RJ, Haider MA, Kucharczyk W, Perlis N. MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial. Radiology. 2021 Mar;298(3):695-703. doi: 10.1148/radiol.2021202717. Epub 2021 Feb 2. Erratum in: Radiology. 2021 May;299(2):E258. PMID: 33529137. Couthor
35. Kwong JCC, McLoughlin LC, Haider M, Goldenberg MG, Erdman L, Rickard M, Lorenzo AJ, Hung AJ, Farcas M, Goldenberg L, Nguan C, Braga LH, Mamdani M, Goldenberg A, Kulkarni GS. Standardized Reporting of Machine Learning Applications in Urology: The STREAM-URO Framework. Eur Urol Focus. 2021 Jul;7(4):672-682. doi: 10.1016/j.euf.2021.07.004. Epub 2021 Aug 3. PMID: 34362709.Coauthor
36. Hao R, Namdar K, Liu L, Haider MA, Khalvati F. A Comprehensive Study of Data Augmentation Strategies for Prostate Cancer Detection in Diffusion-Weighted MRI Using Convolutional Neural Networks. J Digit Imaging. 2021 Aug;34(4):862-876. doi: 10.1007/s10278-021-00478-7. Epub 2021 Jul 12. PMID: 34254200; PMCID: PMC8455796.Coauthor
37. Deniffel D, Healy GM, Dong X, Ghai S, Salinas-Miranda E, Fleshner N, Hamilton R, Kulkarni G, Toi A, van der Kwast T, Zlotta A, Finelli A, Perlis N, Haider MA. Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer. Radiology. 2021 May 25:204112. doi: 10.1148/radiol.2021204112. Epub ahead of print. PMID: 34032510. Senior Responsible Author
38. Ivanics T, Salinas-Miranda E, Abreu P, Khalvati F, Namdar K, Dong X, Deniffel D, Gorgen A, Erdman L, Jhaveri K, Haider M, Veit-Haibach P, Sapisochin G. A Pre-TACE Radiomics Model to Predict HCC Progression and Recurrence in Liver Transplantation: A Pilot Study on a Novel Biomarker. Transplantation. 2021 Nov 1;105(11):2435-2444. doi: 10.1097/TP.0000000000003605. PMID: 33982917.Coauthor
39. Bui TL, Glavis-Bloom J, Chahine C, Mehta R, Wolfe T, Bhatter P, Rupasinghe M, Carbone J, Haider MA, Giganti F, Giona S, Oto A, Lee G, Houshyar R. Prostate minimally invasive procedures: complications and normal vs. abnormal findings on multiparametric magnetic resonance imaging (mpMRI). Abdom Radiol (NY). 2021 Sep;46(9):4388-4400. doi: 10.1007/s00261-021-03097-6. Epub 2021 May 11. PMID: 33977352; PMCID: PMC8346422. Coauthor
40. Salinas-Miranda E, Deniffel D, Dong X, Healy GM, Khalvati F, O'Kane GM, Knox J, Bathe OF, Baracos VE, Gallinger S, Haider MA. Prognostic value of early changes in CT-measured body composition in patients receiving chemotherapy for unresectable pancreatic cancer. Eur Radiol. 2021 Nov;31(11):8662-8670. doi: 10.1007/s00330-021-07899-6. Epub 2021 May 2. PMID: 33934171.Senior Responsible Author
41. Klotz L, Pavlovich CP, Chin J, Hatiboglu G, Koch M, Penson D, Raman S, Oto A, Fütterer J, Serrallach M, Relle J, Lotan Y, Heidenreich A, Bonekamp D, Haider M, Tirkes T, Arora S, Macura KJ, Costa DN, Persigehl T, Pantuck AJ, Bomers J, Burtnyk M, Staruch R, Eggener S. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Cancer. J Urol. 2021 Mar;205(3):769-779. doi: 10.1097/JU.0000000000001362. Epub 2020 Oct 6. PMID: 33021440. Coauthor
42. Liu X, Khalvati F, Namdar K, Fischer S, Lewis S, Taouli B, Haider MA, Jhaveri KS. Can machine learning radiomics provide pre-operative differentiation of combined hepatocellular cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma to inform optimal treatment planning? Eur Radiol. 2021 Jan;31(1):244-255. doi: 10.1007/s00330-020-07119-7. Epub 2020 Aug 4. PMID: 32749585. Coauthor
43. Zhang Y, Lobo-Mueller EM, Karanicolas P, Gallinger S, Haider MA, Khalvati F. Prognostic Value of Transfer Learning Based Features in Resectable Pancreatic Ductal Adenocarcinoma. Front Artif Intell. 2020 Oct 5;3:550890. doi: 10.3389/frai.2020.550890. PMID: 33733206; PMCID: PMC7861273. Co-Senior Responsible Author
44. Panebianco V, Villeirs G, Weinreb JC, Turkbey BI, Margolis DJ, Richenberg J, Schoots IG, Moore CM, Futterer J, Macura KJ, Oto A, Bittencourt LK, Haider MA, Salomon G, Tempany CM, Padhani AR, Barentsz JO. Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical Prostatectomy. Eur Urol Oncol. 2021 Dec;4(6):868-876. doi: 10.1016/j.euo.2021.01.003. Epub 2021 Feb 10. PMID: 33582104.Coauthor
45. Klotz L, Chin J, Black PC, Finelli A, Anidjar M, Bladou F, Machado A, Levental M, Ghai S, Chang S, Milot L, Patel C, Kassam Z, Moore C, Kasivisanathan V, Loblaw A, Kebabdjian M, Earle CC, Pond GR, Haider MA. Comparison of Multiparametric Magnetic Resonance Imaging-Targeted Biopsy With Systematic Transrectal Ultrasonography Biopsy for Biopsy-Naive Men at Risk for Prostate Cancer: A Phase 3 Randomized Clinical Trial. JAMA Oncol. 2021 Feb 4. doi: 10.1001/jamaoncol.2020.7589. Epub ahead of print. PMID: 33538782. Senior Responsible Author
46. Nketiah GA, Elschot M, Scheenen TW, Maas MC, Bathen TF, Selnæs KM; PCa-MAP Consortium. Utility of T2-weighted MRI texture analysis in assessment of peripheral zone prostate cancer aggressiveness: a single-arm, multicenter study. Sci Rep. 2021 Jan 22;11(1):2085. doi: 10.1038/s41598-021-81272-x. PMID: 33483545; PMCID: PMC7822867. Co-author (consortium)
47. Zhang Y, Lobo-Mueller EM, Karanicolas P, Gallinger S, Haider MA, Khalvati F. Improving prognostic performance in resectable pancreatic ductal adenocarcinoma using radiomics and deep learning features fusion in CT images. Sci Rep. 2021 Jan 14;11(1):1378. doi: 10.1038/s41598-021-80998-y. PMID: 33446870; PMCID: PMC7809062. Co-Senior Responsible Author
48. Deniffel D, Abraham N, Namdar K, Dong X, Salinas E, Milot L, Khalvati F, Haider MA. Using decision curve analysis to benchmark performance of a magnetic resonance imaging-based deep learning model for prostate cancer risk assessment. Eur Radiol. 2020 Dec;30(12):6867-6876. doi: 10.1007/s00330-020-07030-1. Epub 2020 Jun 26. PMID: 32591889. Senior Responsible Author
49. Salinas-Miranda E, Khalvati F, Namdar K, Deniffel D, Dong X, Abbas E, Wilson JM, O'Kane GM, Knox J, Gallinger S, Haider MA. Validation of Prognostic Radiomic Features From Resectable Pancreatic Ductal Adenocarcinoma in Patients With Advanced Disease Undergoing Chemotherapy. Can Assoc Radiol J. 2021 Nov;72(4):605-613. doi: 10.1177/0846537120968782. Epub 2020 Nov 5. PMID: 33151087.Senior Responsible Author
50. Perlis N, Finelli A, Lovas M, Berlin A, Papadakos J, Ghai S, Bakas V, Alibhai S, Lee O, Badzynski A, Wiljer D, Lund A, Di Meo A, Cafazzo J, Haider M. Creating patient-centered radiology reports to empower patients undergoing prostate magnetic resonance imaging. Can Urol Assoc J. 2020 Sep 28. doi: 10.5489/cuaj.6585. Epub ahead of print. PMID: 33007175. Senior Responsible Author
51. Alayed Y, Loblaw A, McGuffin M, Chung HT, Tseng CL, D'Alimonte L, Cheung P, Liu S, Chu W, Szumacher E, Helou J, Ravi A, Haider M, Mamedov A, Zhang L, Morton G. Single-fraction HDR brachytherapy as monotherapy in low and intermediate risk prostate cancer: Outcomes from two clinical trials with and without an MRI-guided boost. Radiother Oncol. 2021 Jan;154:29-35. doi: 10.1016/j.radonc.2020.09.007. Epub 2020 Sep 10. PMID: 32918971. Coauthor
52. Schoots IG, Barentsz JO, Bittencourt LK, Haider MA, Macura KJ, Margolis DJA, Moore CM, Oto A, Panebianco V, Siddiqui MM, Tempany C, Turkbey B, Villeirs GM, Weinreb JC, Padhani AR. PI-RADS Committee Position on MRI Without Contrast Medium in Biopsy-Naive Men With Suspected Prostate Cancer: Narrative Review. AJR Am J Roentgenol. 2021 Jan;216(1):3-19. doi: 10.2214/AJR.20.24268. Epub 2020 Nov 19. PMID: 32812795.. Coauthor
53. Finelli A, Cheung DC, Al-Matar A, Evans AJ, Morash CG, Pautler SE, Siemens, DR, Tanguay S, Rendon RA, Gleave ME, Drachenberg DE, Chin JL, Fleshner NE, Haider MA, Kachura JR, Sykes J, Jewett MAS. Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort. Eur Urol. 2020 Jul 14:S0302-2838(20)30513-3. doi: 10.1016/j.eururo.2020.06.053. Epub ahead of print. PMID: 32680677. Coauthor
54. Deniffel D, Salinas E, Ientilucci M, Evans AJ, Fleshner N, Ghai S, Hamilton R, Roberts A, Toi A, van der Kwast T, Zlotta A, Finelli A, Haider MA, Perlis N. Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes? J Urol. 2020 Dec;204(6):1187-1194. doi: 10.1097/JU.0000000000001157. Epub 2020 Jun 4. PMID: 32496160. Co-Senior Responsible Author
55. Klotz L, Pond G, Loblaw A, Sugar L, Moussa M, Berman D, Van der Kwast T, Vesprini D, Milot L, Kebabdjian M, Fleshner N, Ghai S, Chin J, Haider M. Randomized Study of Systematic Biopsy Versus Magnetic Resonance Imaging and Targeted and Systematic Biopsy in Men on Active Surveillance (ASIST): 2-year Postbiopsy Follow-up. Eur Urol. 2020 Mar;77(3):311-317. doi: 10.1016/j.eururo.2019.10.007. Epub 2019 Nov 8. PMID: 31708295. Senior Responsible Author
56. van der Kwast TH, Helleman J, Nieboer D, Bruinsma SM, Roobol MJ; Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) Consortium, Trock B, Ehdaie B, Carroll P, Filson C, Kim J, Logothetis C, Morgan T, Klotz L, Pickles T, Hyndman E, Moore CM, Gnanapragasam V, Van Hemelrijck M, Dasgupta P, Bangma C, Roobol M, Villers A, Rannikko A, Valdagni R, Perry A, Hugosson J, Rubio-Briones J, Bjartell A, Hefermehl L, Shiong LL, Frydenberg M, Kakehi Y, Chung BH, van der Kwast T, Obbink H, van der Linden W, Hulsen T, de Jonge C, Kattan M, Xinge J, Muir K, Lophatananon A, Fahey M, Steyerberg E, Nieboer D, Zhang L, Guo W, Benfante N, Cowan J, Patil D, Tolosa E, Kim TK, Mamedov A, LaPointe V, Crump T, Kimberly-Duffell J, Santaolalla A, Nieboer D, Olivier JT, Rancati T, Ahlgren H, Mascarós J, Löfgren A, Lehmann K, Lin CH, Hirama H, Lee KS, Jenster G, Auvinen A, Bjartell A, Haider M, van Bochove K, Carter B, Gledhill S, Buzza M, Bangma C, Roobol M, Bruinsma S, Helleman J. Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies. Eur Urol Oncol. 2019 May;2(3):333-336. doi: 10.1016/j.euo.2018.08.017. Epub 2018 Sep 13. PMID: 31200849. Coauthor
57. Dulhanty C, Wang L, Cheng M, Gunraj H, Khalvati F, Haider MA, Wong A. Radiomics Driven Diffusion Weighted Imaging Sensing Strategies for Zone-Level Prostate Cancer Sensing. Sensors. 2020; 20(5):1539. Coauthor
58. Zhang Y, Lobo-Mueller EM, Karanicolas P, Gallinger S, Haider MA, Khalvati F. CNN-based survival model for pancreatic ductal adenocarcinoma in medical imaging. BMC Med Imaging. 2020 Feb 3;20(1):11. doi: 10.1186/s12880-020-0418-1. PubMed PMID: 32013871; PubMed Central PMCID: PMC6998249. Co-Senior Responsible Author
59. Deniffel D, Zhang Y, Salinas E, Satkunasivam R, Khalvati F, Haider MA. Reducing Unnecessary Prostate Multiparametric Magnetic Resonance Imaging by Using Clinical Parameters to Predict Negative and Indeterminate Findings. J Urol. 2020 Feb;203(2):292-298. doi: 10.1097/JU.0000000000000518. Epub 2019 Sep 3. PubMed PMID: 31479397. Senior Responsible Author
60. Yoo S, Gujrathi I, Haider MA, Khalvati F. Prostate Cancer Detection using Deep Convolutional Neural Networks. Sci Rep. 2019 Dec 20;9(1):19518. Co-Senior Responsible Author
61. Lo G, Burton KR, Haider MA, Fleshner N, Finelli A, Ghai S. Negative Predictive Value of Prostate Multiparametric Magnetic Resonance Imaging among Men with Negative Prostate Biopsy and Elevated Prostate Specific Antigen: A Clinical Outcome Retrospective Cohort Study. J Urol. 2019 Dec;202(6):1159-1165. doi:10.1097/JU.0000000000000388. PubMed PMID: 31188731.Coauthor
62. Goldberg H, Ahmad AE, Chandrasekar T, Klotz L, Emberton M, Haider MA, Taneja SS, Arora K, Fleshner N, Finelli A, Perlis N, Tyson MD, Klaassen Z, Wallis CJD. Comparison of Magnetic Resonance Imaging and Transrectal Ultrasound Informed Prostate Biopsy for Prostate Cancer Diagnosis in Biopsy Naïve Men: A Systematic Review and Meta-Analysis. J Urol. 2020 Jun;203(6):1085-1093. doi:10.1097/JU.0000000000000595. Epub 2019 Oct 14. PMID: 31609177.. Coauthor
63. Alayed Y, D'Alimonte L, Helou J, Ravi A, Morton G, Chung HT, Haider M, McGuffin M, Zhang L, Loblaw A. MRI assisted focal boost integrated with HDR monotherapy study in low and intermediate risk prostate cancer (MARS): Results from a phase II clinical trial. Radiother Oncol. 2019 Dec;141:144-148. doi: 10.1016/j.radonc.2019.09.011. Epub 2019 Sep 26. PMID: 31564554.Coauthor
64. Lee SL, Ravi A, Morton G, Loblaw A, Tseng CL, Haider M, Murgic J, Nicolae A, Semple M, Chung HT. Changes in ADC and T2-weighted MRI-derived radiomic features in patients treated with focal salvage HDR prostate brachytherapy for local recurrence after previous external-beam radiotherapy. Brachytherapy. 2019 Sep -Oct;18(5):567-573. doi: 10.1016/j.brachy.2019.04.006. Epub 2019 May 22. PubMed PMID: 31126856.Coauthor
65. Murgic J, Morton G, Loblaw A, D'Alimonte L, Ravi A, Wronski M, Davidson M, Haider M, Commisso K, Zhang L, Chung HT. Focal Salvage High Dose-Rate Brachytherapy for Locally Recurrent Prostate Cancer After Primary Radiation Therapy Failure: Results From a Prospective Clinical Trial. Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):561-567. Epub 2018 Jul 2. PubMed PMID: 30244878. Coauthor
66. Maas MC, Litjens GJS, Wright AJ, Attenberger UI, Haider MA, Helbich TH, Kiefer B, Macura KJ, Margolis DJA, Padhani AR, Selnæs KM, Villeirs GM, Fütterer JJ, Scheenen TWJ. A Single-Arm, Multicenter Validation Study of Prostate Cancer Localization and Aggressiveness With a Quantitative Multiparametric Magnetic Resonance Imaging Approach. Invest Radiol. 2019 Apr 3. Coauthor
67. Khalvati F, Zhang Y, Baig S, Lobo-Mueller EM, Karanicolas P, Gallinger S, Haider MA. Prognostic Value of CT Radiomic Features in Resectable Pancreatic Ductal Adenocarcinoma. Sci Rep. 2019 Apr 1;9(1):5449. Senior Responsible Author
68. Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ, Tempany CM, Choyke PL, Cornud F, Margolis DJ, Thoeny HC, Verma S, Barentsz J, Weinreb JC. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol. 2019 Mar 18. pii: S0302-2838(19)30180-0. Coauthor
69. Zhang M, Milot L, Khalvati F, Sugar L, Downes M, Baig SM, Klotz L, Haider MA. Value of Increasing Biopsy Cores per Target with Cognitive MRI-targeted Transrectal US Prostate Biopsy. Radiology. 2019 Jan 29:180712. Senior Responsible Author
70. Cheung HMC, Karanicolas PJ, Hsieh E, Coburn N, Maraj T, Kim JK, Elhakim H, Haider MA, Law C, Milot L. Late gadolinium enhancement of colorectal liver metastases post-chemotherapy is associated with tumour fibrosis and overall survival post-hepatectomy. Eur Radiol. 2018 Aug;28(8):3505-3512. Coauthor
71. Murgic J, Morton G, Loblaw A, D'Alimonte L, Ravi A, Wronski M, Davidson M, Haider M, Commisso K, Zhang L, Chung HT. Focal Salvage High Dose-Rate Brachytherapy for Locally Recurrent Prostate Cancer After Primary Radiation Therapy Failure: Results From a Prospective Clinical Trial.. Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):561-567. doi: 10.1016/j.ijrobp.2018.06.039. Epub 2018 Jul, Coauthor
72. Klotz L, Loblaw A, Sugar L, Moussa M, Berman DM, Van der Kwast T, Vesprini D, Milot L, Kebabdjian M, Fleshner N, Ghai S, Chin J, Pond GR, Haider M. Active Surveillance Magnetic Resonance Imaging Study (ASIST): Results of a Randomized Multicenter Prospective Trial. Eur Urol. 2018 Jul 12. pii: S0302-2838(18)30450-0. Senior Responsible Author
73. Khalvati F, Zhang J, Chung AG, Shafiee MJ, Wong A, Haider MA. MPCaD: A multi-scale radiomics-driven framework for automated prostate cancer localization and detection. BMC Med Imaging. 2018 May 16;18(1):16. Senior Responsible Author
74. Ghai S, Perlis N, Lindner U, Hlasny E, Haider MA, Finelli A, Zlotta AR, Kulkarni GS, van der Kwast TH, McCluskey SA, Kucharczyk W, Trachtenberg J. Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer - phase 1 trial. Eur Radiol. 2018 Oct;28(10):4281-4287. Coauthor
75. Oikonomou A, Khalvati F, Tyrrell PN, Haider MA, Tarique U, Jimenez-Juan L, Tjong MC, Poon I, Eilaghi A, Ehrlich L, Cheung P. Radiomics analysis at PET/CT contributes to prognosis of recurrence and survival in lung cancer treated with stereotactic body radiotherapy. Sci Rep. 2018 Mar 5;8(1):4003. Coauthor
76. Moore CM, Giganti F, Albertsen P, Allen C, Bangma C, Briganti A, Carroll P, Haider M, Kasivisvanathan V, Kirkham A, Klotz L, Ouzzane A, Padhani AR, Panebianco V, Pinto P, Puech P, Rannikko A, Renard-Penna R, Touijer K, Turkbey B, van Poppel H, Valdagni R, Walz J, Schoots I. Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations-A Report of a European School of Oncology Task Force. Eur Urol. 2017 Apr;71(4):648-655. doi: 10.1016/j.eururo.2016.06.011. Coauthor
77. Clark T, Zhang J, Baig S, Wong A, Haider MA, Khalvati F. Fully automated segmentation of prostate whole gland and transition zone in diffusion-weighted MRI using convolutional neural networks. J Med Imaging (Bellingham). 2017 Oct;4(4):041307. Epub 2017 Oct 17. Co-Senior Responsible Author
78. Shafiee MJ, Chung AG, Khalvati F, Haider MA, Wong A. Discovery radiomics via evolutionary deep radiomic sequencer discovery for pathologically proven lung cancer detection. J Med Imaging (Bellingham). 2017 Oct;4(4):041305. Coauthor
79. Loblaw A, Souter LH, Canil C, Breau RH, Haider M, Jamnicky L, Morash R, Surchin M, Matthew A. Follow-up Care for Survivors of Prostate Cancer - Clinical Management: a Program in Evidence-Based Care Systematic Review and Clinical Practice Guideline. Clin Oncol (R Coll Radiol). 2017 Sep 16. Coauthor
80. Eilaghi A, Baig S, Zhang Y, Zhang J, Karanicolas P, Gallinger S, Khalvati F, Haider MA. CT texture features are associated with overall survival in pancreatic ductal adenocarcinoma - a quantitative analysis. BMC Med Imaging. 2017 Jun 19;17(1):38. Senior Responsible Author
81. Zhang Y, Oikonomou A, Wong A, Haider MA, Khalvati F. Radiomics-based Prognosis Analysis for Non-Small Cell Lung Cancer. Sci Rep. 2017 Apr 18;7:46349. Coauthor
82. Haider MA, Yao X, Loblaw A, Finelli A. Evidence-based guideline recommendations on multiparametric magnetic resonance imaging in the diagnosis of prostate cancer: A Cancer Care Ontario clinical practice guideline. Can Urol Assoc J. 2017 Jan-Feb;11(1-2):E1-E7. Principal Author
83. Haider MA, Vosough A, Khalvati F, Kiss A, Ganeshan B, Bjarnason GA. CT texture analysis: a potential tool for prediction of survival in patients with metastatic clear cell carcinoma treated with sunitinib. Cancer Imaging. 2017 Jan 23;17(1):4. Principal Author
84. Salerno J, Finelli A, Morash C, Morgan SC, Power N, Schieda N, Haider MA. Multiparametric magnetic resonance imaging for pre-treatment local staging of prostate cancer: A Cancer Care Ontario clinical practice guideline. Can Urol. Assoc J. 2016 Sep-Oct;10(9-10):E332-E339. Senior Responsible Author
85. Downes MR, Gibson E, Sykes J, Haider M, van der Kwast TH, Ward A. Determination of the Association Between T2-weighted MRI and Gleason Sub-pattern: A Proof of Principle Study. Acad Radiol. 2016 Nov;23(11):1412-1421. Coauthor
86. Li E, Khalvati F, Shafiee MJ, Haider MA, Wong A. Sparse reconstruction of compressive sensing MRI using cross-domain stochastically fully connected conditional random fields. BMC Med Imaging. 2016 Aug 26;16(1):51 Coauthor
87. Khalvati F, Zhang J, Haider MA, Wong A, Khalvati F, Haider MA. Enhanced dual-stage correlated diffusion imaging. Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:5537-5540. Coauthor
88. Boroomand A, Li E, Shafiee MJ, Haider MA, Khalvati F, Wong A, Wong A. A unified Bayesian-based compensated magnetic resonance imaging. Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:1192-1195. Coauthor
89. Ramsay E, Mougenot C, Staruch R, Boyes A, Kazem M, Bronskill M, Foster H, Sugar L, Haider M, Klotz L, Chopra R. Evaluation of focal ablation of MRI-defined prostate cancer using MRI-controlled transurethral ultrasound therapy with prostatectomy as the reference standard. J Urol. 2016 Aug 18. [Epub ahead of print] Coauthor
90. Boroomand A, Shafiee MJ, Khalvati F, Haider MA, Wong A. Noise-Compensated, Bias-Corrected Diffusion Weighted Endorectal Magnetic Resonance Imaging via a Stochastically Fully-Connected Joint Conditional Random Field Model. IEEE Trans Med Imaging. 2016 Dec;35(12):2587-2597. Epub 2016 Jul 7.Coauthor
91. Gibson E, Bauman GS, Romagnoli C, Cool DW, Bastian-Jordan M, Kassam Z, Gaed M, Moussa M, Gomez JA, Pautler SE, Chin JL, Crukley C, Haider MA, Fenster A, Ward AD. Toward Prostate Cancer Contouring Guidelines on Magnetic Resonance Imaging: Dominant Lesion Gross and Clinical Target Volume Coverage Via Accurate Histology Fusion. Int J Radiat Oncol Biol Phys. 2016;96(1):188–196. Coauthor
92. Rosenkrantz AB, Verma S, Choyke P, Eberhardt SC, Eggener SE, Gaitonde K, Haider MA, Margolis DJ, Marks LS, Pinto P, Sonn GA, Taneja SS. Prostate MRI and MRI-Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement of the American Urological Association and the Society of Abdominal Radiology's Prostate Cancer Disease-Focused Panel. J Urol. 2016 Dec;196(6):1613-1618. Coauthor
93. Hwang YH, Conklin J, Chan W, Roslin NM, Liu J, He N, Wang K, Sundsbak JL, Heyer CM, Haider M, Paterson AD, Harris PC, Pei Y. Refining Genotype-Phenotype Correlation in Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol.2016 Jun;27(6):1861-8 Coauthor.
94. Haider MA, Yao X, Loblaw A, Finelli A. Multiparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer: A Systematic Review. Clin Oncol (RColl Radiol). 2016 Sep;28(9):550-67. Principal Author
95. Eli Gibson, Glenn S. Bauman, Cesare Romagnoli, Derek W. Cool, Matthew Bastian-Jordan, Zahra Kassam, Mena Gaed, Madeleine Moussa, José A. Gómez, Stephen E. Pautler, Joseph L. Chin, Cathie Crukley, MA Haider, Aaron Fenster, Aaron D. Ward, "Toward prostate cancer contouring guidelines on MRI: dominant lesion gross and clinical target volume coverage via accurate histology fusion", International Journal of Radiation Oncology Biology Physics, 2016.04.018 (in press). Coauthor
96. Nam RK, Wallis CJD, Stojcic-Bendavid J, Milot L, Sherman C, Sugar L, Haider MA. A Pilot Study to Evaluate the Role of Magnetic Resonance Imaging for Prostate Cancer Screening in the General Population. J Urol. United States; 2016;196(2):361–366. Senior Responsible Author
97. Weinreb JC, Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ, Margolis D, Schnall MD, Shtern F, Tempany CM, Thoeny HC, Verma S. PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol. 2016;69(1):16-40. Coauthor.
98. Barentsz JO, Weinreb JC, Verma S, Thoeny HC, Tempany CM, Shtern F, Padhani AR, Margolis D, Macura KJ, Haider MA, Cornud F, Choyke PL. Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use. Eur Urol. 2016;69(1):41-9. Coauthor.
99. Kim SM, Haider MA, Jaffray DA, Yeung IW. Improved accuracy of quantitative parameter estimates in dynamic contrast-enhanced CT study with low temporal resolution. Med Phys. 2016: 43(1):388. Coauthor.
100. Milosevic MF, Townsley CA, Chaudary N, Clarke B, Pintilie M, Fan S, Glicksman R, Haider MA, Kim S, MacKay H, Yeung I, Hill RP, Gyles A, Oza AM. Sorafenib Increases Tumor Hypoxia in Cervical Cancer Patients Treated with Radiation Therapy: Results of a Phase 1 Clinical Study. Int J Radiat Oncol Biol Phys. 2016: 94(1):111-7. 2016 Coauthor.
101. Khalvati F, Salmanpour A, Rahnamayan S, Haider MA, Tizhoosh HR. Sequential Registration-Based Segmentation of the Prostate Gland in MR Image Volumes. J Digit Imaging. 2016;29(2):254-63. Coauthor.
102. Horgan AM, Darling G, Wong R, Guindi M, Liu G, Jonker DJ, Lister J, Xu W, MacKay HM, Dinniwell R, Kim J, Pierre A, Shargall Y, Asmis TR, Agboola O, Seely AJ, Ringash, J, Wells J, Marginean EC, Haider MA, Knox JJ. Adjuvant sunitinib following chemoradiotherapy and surgery for locally advanced esophageal cancer: a phase II trial. [Epub ahead of print]. Dis Esophagus. 2015. Coauthor.
103. Lui D, Modhafar A, Haider MA, Wong A. Monte Carlo-based noise compensation in coil intensity corrected endorectal MRI. BMC Med Imaging. 2015 Oct 12;15(1):43. Coauthor.
104. Cameron A, Khalvati F, Haider MA, Wong A. MAPS: A Quantitative Radiomics Approach for Prostate Cancer Detection. IEEE Trans Biomed Eng. 2016 Jun:63(6):1145-56. Coauthor.
105. Milosevic MF, Townsley CA, Chaudary N, Clarke B, Pintilie M, Fan S, Glicksman R, Haider M, Kim S, MacKay H, Yeung I, Hill RP, Fyles A, Oza AM. Sorafenib Increases Tumor Hypoxia in Cervical Cancer Patients Treated With Radiation Therapy: Results of a Phase 1 Clinical Study [Epub ahead of print]. Int J Radiat Oncol Biol Phys. 2015 Sep 18. Coauthor.
106. Mehrabian H, Da Rosa M, Haider MA, Martel AL. Pharmacokinetic analysis of prostate cancer using independent component analysis. Magn Reson Imaging. 2015 Dec;33(10):1236-45. Coauthor.
107. Khalvati F, Wong A, Haider MA. Automated prostate cancer detection via comprehensive multi-parametric magnetic resonance imaging texture feature models. BMC Med Imaging. 2015 Aug 5;15(1):27. Senior Responsible Author.
108. Scheenen TW, Rosenkrantz AB, Haider MA, Fütterer JJ. Multiparametric Magnetic Resonance Imaging in Prostate Cancer Management: Current Status and Future Perspectives. Invest Radiol. 2015 Sep;50(9):594-600. Review Coauthor
109. Ghai S, Louis AS, Van Vliet M, Lindner U, Haider MA, Hlasny E, Spensieri P, Van Der Kwast TH, McCluskey SA, Kucharczyk W, Trachtenberg J. Real-Time MRI-Guided Focused Ultrasound for Focal Therapy of Locally Confined Low-Risk Prostate Cancer: Feasibility and Preliminary Outcomes. AJR Am J Roentgenol. 2015 Aug;205(2):W177-84. Coauthor.
110. Da Rosa MR, Milot L, Sugar L, Vesprini D, Chung H, Loblaw A, Pond GR, Klotz L, Haider MA. A prospective comparison of MRI-US fused targeted biopsy versus systematic ultrasound-guided biopsy for detecting clinically significant prostate cancer in patients on active surveillance. J Magn Reson Imaging. 2015;41(1):220–225.; Senior Responsible Author.
111. Ghai S, Haider MA. Multiparametric-MRI in diagnosis of prostate cancer (Review). Indian J Urol. 2015 Jul;31(3):194-201. Senior Responsible Author.
112. Scheenen TW, Rosenkrantz AB, Haider MA, Fütterer JJ. Multiparametric magnetic resonance imaging in prostate cancer management: current status and future perspectives [Epub ahead of print]. Invest Radiol. 2015 May 13. Coauthor.
113. Edwan GA, Ghai S, Margel D, Kulkarni G, Hamilton R, Toi A, Haider MA, Finelli A, Fleshner NE. Magnetic resonance imaging detected prostate evasive anterior tumours: Further insights. Can Urol Assoc J. 2015 May;9(5-6):E267-72. Coauthor.
114. Jewett MA, Rendon R, Lacombe L, Karakiewicz PI, Tanguay S, Kassouf W, Leveridge M, Cagiannos I, Kapoor A, Pautler S, Drachtenberg D, Moore R, Gleave M, Evans A, Haider MA, Finelli A. Canadian guidelines for the management of small renal masses (SRM). Can Urol Assoc J. 2015 May;9(5-6):160-3. Coauthor.
115. Jhaveri K, Cleary S, Audet P, Balaa F, Bhayana D, Burak K, Chang S, Dixon E, Haider MA, Molinari M, Reinhold C, Sherman M. Consensus statements from a multidisciplinary expert panel on the utilization and application of a liver-specific MRI contrast agent (gadoxetic acid) (review). AJR Am J Roentgenol. 2015 Mar;204(3):498-509. Coauthor.
116. Pei Y, Hwang YH, Conklin J, Sundsbak JL, Heyer CM, Chan W, Wang K, He N, Rattansingh A, Atri M, Harris PC, Haider MA. Imaging-based diagnosis of autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2015 Mar;26(3):746-53. Senior Responsible Author.
117. Ménard C, Iupati D, Publicover J, Lee J, Abed J, O’Leary G, Simeonov A, Foltz WD, Milosevic M, Catton C, Morton G, Bristow R, Bayley A, Atenafu EG, Evans AJ, Jaffray DA, Chung P, Brock KK, Haider MA. MR-guided prostate biopsy for planning of focal salvage after radiation therapy. Radiology. 2015 Jan;274(1):181-91. Senior Responsible Author.
118. Shafiee MJ, Haider S, Wong A, Lui D, Cameron A, Modhafar A, Fieguth P, Haider M. Apparent ultra-high b-value diffusion-weighted image reconstruction via hidden conditional random fields. IEEE Trans Med Imaging. 2015 May;34(5):1111-24. Senior Responsible Author.
119. In E, Naguib H, Haider MA. Mechanical stability analysis of carrageenan-based polymer gel for magnetic resonance imaging liver phantom with lesion particles. J Med Imaging (Bellingham). 2014 Oct;1(3):035502. Co-Investigator.
120. Barrett T, Davidson SR, Wilson BC, Weersink RA, Trachtenberg J, Haider MA. Dynamic contrast enhanced MRI as a predictor of vascular-targeted photodynamic focal ablation therapy outcome in prostate cancer post-failed external beam radiation therapy. Can Urol Assoc J. 2014 Sep 1;8(9-10):E708-E714.
121. Wysocka B, Moseley J, Brock K, Lockwood G, Wilson G, Simeonov A, Haider MA, Menard C, Bissonnette JP, Dawson LA, Ringash J. Assessment of nonrespiratory stomach motion in healthy volunteers in fasting and postprandial states. Pract Radiat Oncol. 2014 Sep;4(5):288-93. Coauthor.
122. Moulton CA, Gu CS, Law CH, Tandan VR, Hart R, Quan D, Fairfull Smith RJ, Jalink DW, Husien M, Serrano PE, Hendler AL, Haider MA, Ruo L, Gulenchyn KY,
Finch T, Julian JA, Levine MN, Gallinger S. Effect of PET before liver resection on surgical management for colorectal adenocarcinoma metastases: a randomized clinical trial. JAMA. 2014 May 14;311(18):1863-9. Coauthor.
123. Lui D, Modhafar A, Glaister J, Wong A, Haider MA. Monte carlo bias field correction in endorectal diffusion imaging. IEEE Trans Biomed Eng. 2014 Feb;61(2):368-80. Coauthor.
124. Haider MA, Krieger A, Elliott C, Da Rosa MR, Milot L. Prostate imaging: evaluation of a reusable two-channel endorectal receiver coil for MR imaging at 1.5 T. Radiology. 2014 Feb;270(2):556-65. Principal Author.
125. Organ M, Jewett M, Basiuk J, Morash C, Pautler S, Siemens DR, Tanguay S,
Gleave M, Drachenberg D, Chow R, Chin J, Evans A, Fleshner N, Gallie B, Haider M, Kachura J, Finelli A, Rendon RA. Growth kinetics of small renal masses: A prospective analysis from the Renal Cell Carcinoma Consortium of Canada. Can Urol Assoc J. 2014 Jan;8(1-2):24-7. Coauthor.
126. Cepek J, Lindner U, Davidson SR, Haider MA, Ghai S, Trachtenberg J, Fenster A. Treatment planning for prostate focal laser ablation in the face of needle placement uncertainty. Med Phys. 2014 Jan;41(1):013301. Coauthor.
127. Cameron A, Modhafar A, Khalvati F, Lui D, Shafiee MJ, Wong A, Haider M. Multiparametric MRI prostate cancer analysis via a hybrid morphological-textural model. Conf Proc IEEE Eng Med Biol Soc. 2014;2014:3357-60. Senior Responsible Author.
128. Zukotynski K, Haider MA. Imaging in prostate carcinoma (review). Hematol Oncol Clin North Am. 2013 Dec;27(6):1163-87, vii-viii. Coauthor.
129. Murphy G, Haider MA, Ghai S, Sreeharsha B. The expanding role of MRI in prostate cancer (review). AJR Am J Roentgenol. 2013 Dec;201(6):1229-38. Coauthor.
130. Ramsay E, Mougenot C, Köhler M, Bronskill M, Klotz L, Haider MA, Chopra R. MR thermometry in the human prostate gland at 3.0T for transurethral ultrasound therapy. J Magn Reson Imaging. 2013 Dec;38(6):1564-71. Coauthor.
131. Arani A, Da Rosa M, Ramsay E, Plewes DB, Haider MA, Chopra R. Incorporating endorectal MR elastography into multi-parametric MRI for prostate cancer imaging: Initial feasibility in volunteers. J Magn Reson Imaging. 2013 Nov;38(5):1251-60. Coauthor.
132. Chan WC, Tejani Z, Budhani F, Massey C, Haider MA. R2* as a surrogate measure of ferriscan iron quantification in thalassemia. J Magn Reson Imaging. 2014;39(4):1007-11.Senior Responsible Author.
133. Wong A, Glaister J, Cameron A, Haider MA. Correlated diffusion imaging. BMC Med Imaging. 2013 Aug 8;13(1):26. Coauthor.
134. Sussman MS, Lindner U, Haider MA, Kucharczyk W, Hlasny E, Trachtenberg J. Optimizing contrast agent concentration and spoiled gradient echo pulse sequence parameters for catheter visualization in MR-guided interventional procedures: an analytic solution. Magn Reson Med. 2013 Aug;70(2):333-40. Coauthor.
135. Sridhar SS, Mackenzie MJ, Hotte SJ, Mukherjee SD, Tannock IF, Murray N, Kollmannsberger C, Haider MA, Chen EX, Halford R, Wang L, Ivy SP, Moore MJ. A phase II study of cediranib (AZD 2171) in treatment naive patients with progressive unresectable recurrent or metastatic renal cell carcinoma: a trial of the PMH phase 2 consortium. Invest New Drugs. 2013 Aug;31(4):1008-15. Coauthor.
136. Bauman G, Haider MA, Van der Heide UA, Ménard C. Boosting imaging defined dominant prostatic tumors: a systematic review (review). Radiother Oncol. 2013 Jun;107(3):274-81. Coauthor.
137. Foltz WD, Wu A, Chung P, Catton C, Bayley A, Milosevic M, Bristow R, Warde P, Simeonov A, Jaffray DA, Haider MA, Ménard C. Changes in apparent diffusion coefficient and T2 relaxation duing radiotherapy for prostate cancer. J Magn Reson Imaging. 2013 Apr;37(4):909-16. Coauthor.
138. Jhaveri KS, Cleary SP, Fischer S, Haider MA, Pargoankar V, Khalidi K, Moshonov H, Gallinger S. Blood oxygen level-dependent liver MRI: can it predict microvascular invasion in HCC? J Magn Reson Imaging. 2013 Mar;37(3):692-9. Coauthor.
139. Milot L, Ma K, Efford E, Sela G, Coburn N, Haider MA, Piron C, Plewes D, Law C. Evaluation of a multimodality MR/US coregistration system for investigation of hepatic metastases from colorectal cancer. J Vasc Interv Radiol. 2013 Mar;24(3):357-62. Coauthor.
140. Kim SM, Haider MA, Milosevic M, Yeung IW. A comparison of dynamic contrast-enhanced CT and MR imaging-derived measurements in patients with cervical cancer. Clin Physiol Funct Imaging. 2013 Mar;33(2):150-61. Coauthor.
141. Lindner U, Ghai S, Spensieri P, Hlasny E, van der Kwast TH, McCluskey SA, Haider MA (C), Kucharczyk W, Trachtenberg J. Focal magnetic resonance-guided focused ultraasound for prostate cancer: initial North American experience. Can Urol Assoc. J. 2012 Dec;6(6):E283-6. Coauthor.
142. Heyn C, Sue-Chue-Lam D, Jhaveri K, Haider MA. MRI of the pancreas: problem solving tool. J Magn Reson Imaging. 2012 Nov;36(5):1037-51. Senior Responsible Author.
143. Chopra R, Colquhoun A, Burtnyk M, N’djin WA, Kobelevskiy I, Boyes A, Siddiqui K, Foster H, Sugar L, Haider MA, Bronskill M, Klotz L. MR imaging-controlled transurethral ultrasound therapy for conformal treatment of prostate tissue: initial feasibility in humans. Radiology. 2012 Oct;265(1):303-13. Coauthor.
144. Milot L, Haider MA, Foster L, McGregor C, Law C. Gadofosveset trisodium in the investigation of focal liver lesions in noncirrhotic liver: Early experience. J Magn Reson Imaging. 2012 Sep;36(3):738-42. Coauthor.
145. Verma S, Turkbey B, Muradyan N, Rajesh A, Cornud F, Haider MA, Choyoke PL, Harisinghani M. Overview of dynamic contrast-enhanced MRI in prostate cancer diagnosis and management. AJR Am J Roentgenol. 2012 Jun;198(6):1277-88. Coauthor.
146. Margel D, Yap SA, Lawrentschuk N, Klotz L, Haider MA, Hersey K, Finelli A, Zlotta A, Trachtenberg J, Fleshner N. Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: a prospective cohort study. J Urol. 2012 Apr;187(4):1247-52. Coauthor.
147. Al-Sukhni W, Borgida A, Rothenmund H, Holter S, Semotiuk K, Grant R, Wilson S, Moore M, Narod S, Jhaveri K, Haider MA, Gallinger S. Screening for Pancreatic Cancer in a High-Risk Cohort: An Eight-Year Experience. J Gastrointest Surg. 2012 Apr; 16(4): 771-83. Coauthor.
148. Chopra S. Toi, A. Taback N, Evans A, Haider MA, Milosevic M, Bristow RG, Chung P, Bayley A, Morton G, Vesprini D, Warde P, Catton C, Ménard C. Pathological predictors for site of local recurrence after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e441-8. Coauthor.
149. Elser C, Sweet J, Cheran SK, Haider MA, Jewett M, Sridhar SS. A case of metastatic urachal adenocarcinoma treated with several different chemotherapeutic regimens. Can Urol Assoc J. 6(1):E27-31. Coauthor.
150. Jewett M, Finelli A, Kollmannsberger C, Wood L, Legere L, Basiuk J, Canil C, Heng D, Reaume N, Tanguay S, Atkins M, Bjarnason G, Dancey J, Evans M, Fleshner N, Haider MA, Kapoor A, Uzzo R, Maskens D, Soulieres D, Yousef G, Basappa N, Bendali N, Black P, Blais N, Cagiannos I, Care M, Chow R, Chung H, Czaykowski P, Derosa D, Durrant K, Ellard S, Farquharson G, Filion-Brulotte C, Gingerich J, Godbout L, Grant R, Hamilton W, Kassouf W, Kurban G, Lane K, Lattouf J, Lau D, Leveridge M, McCarthy J, Moore R, North S, O’brien P, Pituskin E, Racine P, Rendon R, So A, Sridhar S, Stubbs K, Su Z, Taylor L, Udall T, Venner P, Vogel W, Yap S, Yau P, Cooper M, Giroux N, Miron D, Mosher D, Ross K, Willacy J. Management of kidney cancer: Canadian kidney cancer forum consensus update 2011. Can Urol Assoc J. 6(1):16-22. Coauthor.
151. Glaister J, Cameron A, Wong A, Haider MA. Quantitative investigative analysis of tumour separability in the prostate gland using ultra-high b-value computed diffusion imaging. Conf Proc IEEE Eng Med Biol Soc. 2012;2012:420-3. Coauthor.
152. Cameron A, Glaister J, Wong A, Haider MA. Non-parametric Bayesian estimation of apparent diffusion coefficient from diffusion-weighted magnetic resonance imaging data. Conf Proc IEEE Eng Med Biol Soc. 2012;2012:412-5. Coauthor.
153. Kim SM, Haider MA, Milosevic M, Jaffray DA, Yeung IW. A method for patient dose reduction in dynamic contrast enhanced CT study. Med Phys. 2011 Sep;38(9):5094-103. Coauthor.
154. Ménard A, Tomlinson G, Cleary S, Wei A, Gallinger S, Haider MA. Serous cystadenomas of the pancreas: long-term follow-up measurement of growth rate. Canadian Association of Radiologists Journal. 2011 Aug;62(3):190-6. Senior Responsible Author.
155. Jewett MA, Mattar K, Basiuk J, Morash CG, Pautler SE, Siemens DR, Tanguay S, Rendon RA, Gleave ME, Drachenberg DE, Chow R, Chung H, Chin JL, Fleshner NE, Evans AJ, Gallie BL, Haider MA, Kachura JR, Kurban G, Fernandes K, Finelli A. Active surveillance of small renal masses: progression patterns of early stage kidney cancer. European Urology. 2011 Jul. 2011 Jul;60(1):39-44. Coauthor.
156. Kim TK, Lee KH, Jang HJ, Haider MA (C), Jacks LM, Menezes RJ, Park SH, Yazdi L, Sherman M, Khalili K. Analysis of gadobenate dimeglumine-enhanced MR findings for characterizing small (1-2-cm) hepatic nodules in patients at high risk for hepatocellular carcinoma. Radiology. 2011 Jun;259(3):730-8. Coauthor.
157. Khalili K, Kim TK, Jang HJ, Haider MA, Khan L, Guindi M, Sherman M. Optimization of imaging diagnosis of 1-2 cm heptocellular carcinoma: analysis of diagnostic performance and resource utilization. J Hepatol. 2011 Apr 54(4): 723-8. Coauthor.
158. Ayyappan AP, Jhaveri KS, Haider MA. Radiological assessment of mesenteric and retroperitoneal cysts in adults: is there are role for chemical shift MRI? Clin Imaging. 2011 Mar-Apr;35(2):127-32. Coauthor.
159. Foltz WD, Haider MA (C), Chung P, Bayley A, Catton C, Ramanan V, Jaffray D, Wright GA, Ménard C. Prostate T(1) quantification using a magnetization-prepared spiral technique. J Magn Reson Imaging. 2011 Feb;33(2):474-81. Coauthor.
160. Eccles CL, Patel R, Simeonov AK, Lockwood G, Haider MA (C), Dawson LA. Comparison of liver tumor motion with and without abdominal compression using cine-magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):602-8. Coauthor.
161. Rajan DK, Margau R, Kroll RR, Simons ME, Tan KT, Jaskolka JD, Kachura JR, Sniderman KW, Beecroft JR, Haider MA. Clinical utility of ultrasound versus magnetic resonance imaging for deciding to proceed with uterine artery embolization for presumed symptomatic fibroids. Clin Radiol. 2011 Jan;66(1):57-62. Coauthor.
162. Liu X, Haider MA, Yetik IS. Unsupervised 3D prostate segmentation based on diffusion-weighted imaging MRI using active contour models with a shape prior. Journal of Electrical and Computer Engineering. Volume 2011 (2011), Article ID 410912, 11 pages. doi:10.1155/2011/410912. Coauthor.
163. Siddiqui K, Chopra R, Vedula S, Sugar L, Haider MA (C), Boyes A, Musquera M, Bronskill M, Klotz L. MRI-guided transurethral ultrasound therapy of the prostate gland using real-time thermal mapping: initial studies. Urology. 2010 Dec;76(6):1506-11. Coauthor.
164. Foltz WD, Chopra S, Chung P, Bayley A, Catton C, Jaffray D, Wright GA, Haider MA (C), Ménard C. Clinical prostate T(2) quantification using magnetization-prepared spiral imaging. Magn Reson Med. 2010 Oct;64(4):1155-61. Coauthor.
165. Knox JJ, Wong R, Visbal AL, Horgan AM, Guindi M, Hornby J, Xu W, Ringash J, Keshavjee S, Chen E, Haider MA (C), Darling G. Phase 2 trial of preoperative irinotecan plus cisplatin and conformal radiotherapy, followed by surgery for esophageal cancer. Cancer. 2010 Sep 1;116(17):4023-32. Coauthor.
166. Artan Y, Haider MA (C), Langer DL, van der Kwast TH, Evans AJ, Yang Y, Wernick MN, Trachtenberg J, Yetik IS. Prostate cancer localization with multispectral MRI using cost-sensitive support vector machines and conditional random fields. IEEE Trans Image Process. 2010 Sep;19(9):2444-55. Coauthor.
167. Raz O, Haider MA (C), Davidson SR, Lindner U, Hlasny E, Weersink R, Gertner MR, Kucharcyzk W, McCluskey SA, Trachtenberg J. Real-time magnetic resonance imaging-guided focal laser therapy in patients with low-risk prostate cancer. Eur Urol. 2010 Jul;58(1):173-7. Coauthor.
168. O’Malley ME, Chung P, Haider MA (C), Jang HJ, Jhaveri K, Khalili K, Panzarella T, Warde P. Comparison of low dose with standard dose abdominal/pelvic multidetector CT in patients with stage 1 testicular cancer under surveillance. Eur Radiol. 2010 Jul;20(7):1624-30. Coauthor.
169. Lindner U, Lawrentschuk N, Weersink RA, Davidson SR, Raz O, Hlasny E, Langer DL, Gertner MR, van der Kwast T, Haider MA (C), Trachtenberg J. Focal laser ablation for prostate cancer followed by radical prostatectomy: validation of focal therapy and imaging accuracy. Eur Urol. 2010 Jun;57(6):1111-4. Coauthor.
170. Yang C, Stadler WM, Karczmar GS, Milosevic M, Yeung I, Haider MA (SRA). Comparison of quantitative parameters in cervix cancer measured by dynamic contrast-enhanced MRI and CT. Magn Reson Med. 2010 Jun;63(6):1601-9. Senior Responsible Author.
171. Langer DL, van der Kwast TH, Evans AJ, Plotkin A, Trachtenberg J, Wilson BC, Haider MA (SRA). Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features. Radiology. 2010 May;255(2):485-94. Senior Responsible Author.
172. Ozer S, Langer DL, Liu X, Haider MA, van der Kwast TH, Evans AJ, Yang Y, Wernick MN, Yetik IS. Supervised and unsupervised methods for prostate cancer segmentation with multispectral MRI. Med Phys. 2010 Apr;37(4):1873-83. Coauthor.
173. Goldenberg AA, Trachtenberg J, Yi Y, Weersink R, Sussman MS, Haider MA, Ma L, Kucharczyk W. Robot-assisted MRI-guided prostatic interventions. Robotica. 2010 Mar. 2010 Mar;28 (Special Issue 02):215-34.
174. Milot L, Guindi M, Gallinger S, Moulton CA, Brock KK, Dawson LA, Haider MA. MR imaging correlates of intratumoral tissue types within colorectal liver metastases: a high-spatial-resolution fresh ex vivo radiologic-pathologic correlation study. Radiology. 2010 Mar;254(3):747-54. Senior Responsible Author.
175. Andreisek G, White LM, Sussman MS, Langer DL, Patel C, Su JW, Haider MA (C), Stainsby JA. T2*-weighted and arterial spin labeling MRI of calf muscles in healthy volunteers and patients with chronic exertional compartment syndrome: preliminary experience. AJR Am J Roentgenol. 2009 Oct;193(4):W327-33. Coauthor.
176. Kim SM, Haider MA (C), Milosevic M, Yeung IW. Interindividual variability of arterial impulse response to intravenous injection of nonionic contrast agent (Iohexol) in DCE-CT study. Med Phys. 2009 Oct;36(10):4791-802. Coauthor.
177. Lindner U, Weersink RA, Haider MA (C), Gertner MR, Davidson SR, Atri M, Wilson BC, Fenster A, Trachtenberg J. Image guided photothermal focal therapy for localized prostate cancer: phase I trial. The Journal of Urology. 2009 Oct;182(4):1371-7. Coauthor.
178. Chopra S, Foltz WD, Milosevic MF, Toi A, Bristow RG, Ménard C, Haider MA. Comparing oxygen-sensitive MRI (BOLD R2*) with oxygen electrode measurements: a pilot study in men with prostate cancer. Int J Radiat Oncol Biol Phys. 2009 Sep;85(9):805-13. Senior Responsible Author.
179. Jhaveri K, Halankar J, Aguirre D, Haider MA, Lockwood G, Guindi M , Fischer S. Intrahepatic bile duct dilatation due to liver metastases from colorectal carcinoma. AJR Am J Roentgenol. 2009 Sep;193(3):752-6. Coauthor.
180. Langer DL, van der Kwast TH, Evans AJ, Trachtenberg J, Wilson BC, Haider MA. Prostate cancer detection with multi-parametric MRI: Logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI. J Magn Reson Imaging. 2009 Aug;30(2):327-34. Senior Responsible Author.
181. Zwahlen D, Jezioranski J, Chan P, Haider MA, Cho YB, Yeung I, Levin W, Manchul L, Fyles A, Milosevic M. Magnetic resonance imaging-guided intracavitary brachytherapy for cancer of the cervix. Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1157-64. Coauthor.
182. Dinniwell R, Chan P, Czarnota G, Haider MA, Jhaveri K, Jewett M, Fyles A, Jaffray D, Milosevic M. Pelvic lymph node topography for radiotherapy treatment planning from ferumoxtran-10 contrast-enhanced magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):844-51. Coauthor.
183. Liu X, Langer DL, Haider MA, Yang Y, Wernick MN, Yetik IS. Prostate cancer segmentation with simultaneous estimation of Markov random field parameters and class. IEEE Trans Med Imaging. 2009 Jun;28(6):906-15. Coauthor.
184. Davidson SR, Weersink RA, Haider MA, Gertner MR, Bogaards A, Giewercer D, Scherz A, Sherar MD, Elhilali M, Chin JL, Trachtenberg J, Wilson BC. Treatment planning and dose analysis for interstitial photodynamic therapy of prostate cancer. Phys Med Biol. 2009 Apr 21;54(8):2293-313. Coauthor.
185. Atri M, Gertner MR, Haider MA, Weersink RA, Trachtenberg J. Contrast-enhanced ultrasonography for real-time monitoring of interstitial laser thermal therapy in the focal treatment of prostate cancer. Can Urol Assoc J. 2009 Apr;3(2):125-30. Coauthor.
186. Noel P, Bammer R, Reinhold C, Haider MA. Parallel imaging artifacts in body magnetic resonance imaging. Can Assoc Radiol J. 2009 Apr;60(2):91-8. Senior Responsible Author.
187. Lawrentschuk N, Haider MA, Daljeet N, Evans A, Toi A, Finelli A, Trachtenberg J, Zlotta A, Fleshner N. ‘Prostatic evasive anterior tumours’: the role of magnetic resonance imaging. BJU International. 2010 May;105(9):1231-6. Senior Responsible Author.
188. Eccles CL, Haider EA, Haider MA, Fung S, Lockwood G, Dawson LA. Change in diffusion weighted MRI during liver cancer radiotherapy: Preliminary observations. Acta Oncol. 2009;48(7):1034-43. Senior Responsible Author.
189. Liu X, Langer DL, Haider MA (C), Van der Kwast TH, Evans AJ, Wernick MN, Yetik IS. Unsupervised segmentation of the prostate using MR images based on level set with a shape prior. Conf Proc IEEE Eng Med Biol Soc. 2009:3613-6. Coauthor.
190. Haider EA, Jhaveri KS, O’Malley ME, Haider MA, Jewett MA, Rendon RA. Magnetic resonance imaging of the urinary bladder: cancer staging and beyond. Can Assoc Radiol J. 2008 Dec;59(5):241-58. Coauthor.
191. Langer DL, van der Kwast TH, Evans AJ, Sun L, Yaffe MJ, Trachtenberg J, Haider MA. Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers. Radiology. 2008 Dec;249(3):900-8. Senior Responsible Author.
192. Kim SM, Cho YB, Haider MA, Milosevic M, Yeung IW. Multiphasic contrast injection for improved precision of parameter estimates in functional CT. Med Phys. 2008 Dec;35(12):5921-33. Coauthor.
193. Vesprini D, Ung Y, Dinniwell R, Breen S, Cheung F, Grabarz D, Kamra J, Mah K, Mansouri A, Pond G, Brock K, Darling G, Knox J, Haider M, Wong RK. Improving observer variability in target delineation for gastro-oesophageal cancer--the role of (18F)fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography. Clin Oncol (R Coll Radiol). 2008 Oct;20(8):631-8. Coauthor.
194. Trachtenberg J, Weersink RA, Davidson SR, Haider MA, Bogaards A, Gertner MR, Evans A, Scherz A, Savard J, Chin JL, Wilson BC, Elhilali M. Vascular-targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses. BJU International. 2008 Aug 5;102(5):556-62. Coauthor.
195. Kirilova A, Lockwood G, Choi P, Bana N, Haider MA, Brock KK, Eccles C, Dawson LA. Three-dimensional motion of liver tumors using cine-magnetic resonance imaging. Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1189-95. Coauthor.
196. Cheng HL, Haider MA, Dill-Macky MJ, Sweet JM, Trachtenberg J, Gertner MR. MRI and contrast-enhanced ultrasound monitoring of prostate microwave focal thermal therapy: An in vivo canine study. J Magn Reson Imaging. 2008 Jul;28(1):136-43. Coauthor.
197. McVeigh PZ, Syed AM, Milosevic M, Fyles A, Haider MA. Diffusion-weighted MRI in cervical cancer. Eur Radiol. 2008 May;18(5):1058-64. Senior Responsible Author.
198. Chan P, Dinniwell R, Haider MA, Cho YB, Jaffray D, Lockwood G, Levin W, Manchul L, Fyles A, Milosevic M. Inter- and intrafractional tumor and organ movement in patients with cervical cancer undergoing radiotherapy: a cinematic-MRI point-of-interest study. Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1507-15. Coauthor.
199. Nadkarni D, Spitzer RF, Kives S, Colgan T, Haider MA, Allen L. Uterine asymmetry and dysmenorrhea in a young woman. J Obstet Gynaecol Can. 2008 Apr;30(4):301-2. Coauthor.
200. Abdalian R, Dhar P, Jhaveri K, Haider MA, Guindi M, Heathcote EJ. Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging. Hepatology. 2008 Mar;47(3):949-57. Coauthor.
201. Haider MA, Chung P, Sweet J, Toi A, Jhaveri K, Ménard C, Warde P, Trachtenberg J, Lockwood G, Milosevic M. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):425-30. Principal Author.
202. Sridhar SS, Haider MA, Guindi M, Moore MJ. A case of small bowel obstruction due to intraluminal metastases from metastatic renal cell cancer. Oncologist. 2008 Feb;13(2):95-7. Coauthor.
203. Lim K, Chan P, Dinniwell R, Fyles A, Haider MA, Cho YB, Jaffray D, Manchul L, Levin W, Hill RP, Milosevic M. Cervical cancer regression measured using weekly magnetic resonance imaging during fractionated radiotherapy: radiobiologic modeling and correlation with tumor hypoxia. Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):126-33. Coauthor.
204. Goldenberg AA, Trachtenberg J, Kucharczyk W, Yi Y, Haider MA, Ma L, Weersink R, Raoufi C. Robotic system for closed-bore MRI-guided prostatic interventions. IEEE/ASME Transactions on Mechatronics. 2008;13:374-9. Coauthor.
205. Lad SV, Haider MA, Brown CJ, McLeod RS. MRI appearance of perianal carcinoma in Crohn’s disease. J Magn Reson Imaging. 2007 Dec;26(6):1659-62. Co-Principal Author.
206. Wiltshire KL, Brock KK, Haider MA, Zwahlen D, Kong V, Chan E, Moseley J, Bayley A, Catton C, Chung PW, Gospodarowicz M, Milosevic M, Kneebone A, Warde P, Ménard C. Anatomic boundaries of the clinical target volume (prostate bed) after radical prostatectomy. Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1090-9. Coauthor.
207. Trachtenberg J, Bogaards A, Weersink RA, Haider MA, Evans A, McCluskey SA, Scherz A, Gertner MR, Yue C, Appu S, Aprikian A, Savard J, Wilson BC, Elhilali M. Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response. J Urol. 2007 Nov;178(5):1974-9. Coauthor.
208. Zand KR, Reinhold C, Haider MA, Nakai A, Rohoman L, Maheshwari S. Artifacts and pitfalls in MR imaging of the pelvis. J Magn Reson Imaging. 2007 Sep;26(3):480-97. Coauthor.
209. Hensel JM, Ménard C, Chung PW, Milosevic MF, Kirilova A, Moseley JL, Haider MA, Brock KK. Development of multiorgan finite element-based prostate deformation model enabling registration of endorectal coil magnetic resonance imaging for radiotherapy planning. Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1522-8. Coauthor.
210. Haider MA, van der Kwast TH, Tanguay J, Evans AJ, Hashmi AT, Lockwood G, Trachtenberg J et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer. AJR Am J Roentgenol. 2007 Aug;189(2):323-8. Principal Author.
211. Haider MA, Davidson SR, Kale AV, Weersink RA, Evans AJ, Toi A, Gertner MR, Bogaards A, Wilson BC, Chin JL, Elhilali M, Trachtenberg J. Prostate gland: MR imaging appearance after vascular targeted photodynamic therapy with palladium-bacteriopheophorbide. Radiology. 2007 Jul;244(1):196-204. Principal Author.
212. Jhaveri KS, Lad SV, Haider MA. Computed tomographic histogram analysis in the diagnosis of lipid-poor adenomas: comparison to adrenal washout computed tomography. J Comput Assist Tomogr. 2007 Jul-Aug;31(4):513-8. Coauthor.
213. Noseworthy MD, Haider MA, Sussman MS, Wright GA. Free-breathing motion compensation using template matching: a technique allowing for tracer kinetic modeling of liver metastases. J Comput Assist Tomogr. 2007 Mar-Apr;31(2):193-7. Co-Principal Author.
214. Haider MA, Sitartchouk I, Roberts TP, Fyles A, Hashmi AT, Milosevic M. Correlations between dynamic contrast-enhanced magnetic resonance imaging-derived measures of tumor microvasculature and interstitial fluid pressure in patients with cervical cancer. J Magn Reson Imaging. 2007 Jan;25(1):153-9. Principal Author.
215. Punnen S, Haider MA, Lockwood G, Moulding F, O’Malley M E, Jewett MA. Variability in size measurement of renal masses smaller than 4 cm on computerized tomography. J Urol. 2006 Dec;176(6 Pt 1):2386-90. Co-Principal Author.
216. Voroney JP, Brock KK, Eccles C, Haider MA, Dawson LA. Prospective comparison of computed tomography and magnetic resonance imaging for liver cancer delineation using deformable image registration. Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):780-91. Coauthor.
217. Jhaveri KS, Wong F, Ghai S, Haider MA. Comparison of CT histogram analysis and chemical shift MRI in the characterization of indeterminate adrenal nodules. AJR Am J Roentgenol. 2006 Nov;187(5):1303-8. Senior Responsible Author
218. Huang Z, Haider MA, Kraft S, Chen Q, Blanc D, Wilson BC, Hetzel FW. Magnetic resonance imaging correlated with the histopathological effect of Pd-bacteriopheophorbide (Tookad) photodynamic therapy on the normal canine prostate gland. Lasers Surg Med. 2006 Aug;38(7):672-81. Co-Principal Author.
219. Chopra R, Wachsmuth J, Burtnyk M, Haider MA, Bronskill MJ. Analysis of factors important for transurethral ultrasound prostate heating using MR temperature feedback. Phys Med Biol. 2006 Feb 21;51(4):827-44. Coauthor.
220. Krzyzanowska MK, Tsao MS, Oza AM, Haider MA (C), Feld R, Knox J, Chin S, Hu H, Siu LL. Capecitabine plus rofecoxib show no activity in patients with metastatic neuroendocrine tumours. Clin Oncol (R Coll Radiol). 2006 Feb;18(1):88-9. Coauthor.
221. Haider MA, Patlas M, Jhaveri K, Chapman W, Fyles A, Rosen B. Adenocarcinoma involving the uterine cervix: magnetic resonance imaging findings in tumours of endometrial, compared with cervical, origin. Can Assoc Radiol J. 2006 Feb;57(1):43-8. Principal Author.
222. Chopra R, Burtnyk M, Haider MA, Bronskill MJ. Method for MRI-guided conformal thermal therapy of prostate with planar transurethral ultrasound heating applicators. Phys Med Biol. 2005 Nov 7;50(21):4957-75. Coauthor.
223. Kirpalani A, Khalili K, Lee S, Haider MA. Renal colic: comparison of use and outcomes of unenhanced helical CT for emergency investigation in 1998 and 2002. Radiology. 2005 Aug;236(2):554-8. Coauthor.
224. Haider MA, Milosevic M, Fyles A, Sitartchouk I, Yeung I, Henderson E, Lockwood G, Lee TY, Roberts TP. Assessment of the tumor microenvironment in cervix cancer using dynamic contrast enhanced CT, interstitial fluid pressure and oxygen measurements. Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1100-7. Principal Author.
225. Macdonald DB, Haider MA, Khalili K, Kim TK, O’Malley M, Greig PD, Grant DR, Lockwood G, Cattral MS. Relationship between vascular and biliary anatomy in living liver donors. AJR Am J Roentgenol. 2005 Jul;185(1):247-52. Senior Responsible Author.
226. Alfuhaid TR, Khalili K, Kirpalani A, Haider MA, Wilson SR, Daneman A. Neoplasms of the inferior vena cava--pictorial essay. Can Assoc Radiol J. 2005 Jun;56(3):140-7. Coauthor.
227. Kim RD, Sakamoto S, Haider MA, Molinari M, Gallinger S, McGilvray ID, Greig PD, Grant DR, Cattral MS. Role of magnetic resonance cholangiography in assessing biliary anatomy in right lobe living donors. Transplantation. 2005 May 27;79(10):1417-21. Co-Principal Author.
228. Metser U, Haider MA, Dill-Macky M, Atri M, Lockwood G, Minden M. Fungal liver infection in immunocompromised patients: depiction with multiphasic contrast-enhanced helical CT. Radiology. 2005 Apr;235(1):97-105. Senior Responsible Author.
229. Ghai S, Dill-Macky M, Wilson S, Haider MA. Fluid-fluid levels in cavernous hemangiomas of the liver: baffled? AJR Am J Roentgenol. 2005 Mar;184(3 Suppl):S82-5. Senior Responsible Author.
230. Riddell A, Jhaveri K, Haider MA. Pseudocyst rupture into the portal vein diagnosed with MRI. Br J Radiol. 2005 Mar;78(927):265-8. Coauthor.
231. Haider MA, Ghai S, Jhaveri K, Lockwood G. Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role? Radiology. 2004 Jun;231(3):711-6. Principal Author.
232. Lee KH, O’Malley ME, Haider MA, Hanbidge A. Triple-phase MDCT of hepatocellular carcinoma. AJR Am J Roentgenol. 2004 Mar;182(3):643-9. Co-Principal Author.
233. Volpe A, Panzarella T, Rendon RA, Haider MA, Kondylis FI, Jewett MA. The natural history of incidentally detected small renal masses. Cancer. 2004 Feb 15;100(4):738-45. Coauthor.
234. Taussky D, Haider MA, McLean M, Yeung I, Williams T, Pearson S, Lockwood G, Crook J. Factors predicting an increased dose to the penile bulb in permanent seed prostate brachytherapy. Brachytherapy. 2004;3(3):125-9. Coauthor.
235. Burn PR, Haider MA, Alfuhaid T, Brown MP, Roberts TP. Proton magnetic resonance spectroscopy as a potential tool for differentiating between abdominal fluid collections. J Magn Reson Imaging. 2003 Dec;18(6):740-4. Senior Responsible Author.
236. O’Riordan E, Haider MA, O’Malley ME, Khalili K, Ibach K, Lockwood GA, Bahadorani B. Manually respiratory-triggered single-shot fast spin-echo: a non-breath-hold T2-weighted method for liver lesion detection. Can Assoc Radiol J. 2003 Dec;54(5):289-95. Senior Responsible Author.
237. Haider MA. Extending PowerPoint with DICOM image support. Radiographics. 2003 Nov-Dec;23(6):1683-7. Principal Author.
238. Sherar MD, Trachtenberg J, Davidson SR, McCann C, Yue CK, Haider MA, Gertner MR. Interstitial microwave thermal therapy for prostate cancer. J Endourol. 2003 Oct;17(8):617-25. Coauthor.
239. Henderson E, Milosevic MF, Haider MA, Yeung IW. Functional CT imaging of prostate cancer. Phys Med Biol. 2003 Sep 21;48(18):3085-100. Coauthor.
240. Lee KH, O’Malley ME, Kachura JR, Haider MA, Hanbidge A. Hepatocellular carcinoma: imaging and imaging-guided Intervention (pictorial essay). AJR Am J Roentgenol. 2003 Apr;180(4):1015-22. Coauthor.
241. Metser U, Haider MA, Khalili K, Boerner S. MR imaging findings and patterns of spread in secondary tumor involvement of the uterine body and cervix. AJR Am J Roentgenol. 2003 Mar;180(3):765-9. Senior Responsible Author.
242. Parker CC, Damyanovich A, Haycocks T, Haider MA, Bayley A, Catton CN. Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration. Radiotherapy and Oncology. 2003 Feb;66(2):217-24. Coauthor.
243. Haider MA, Amitai MM, Rappaport DC, O’Malley ME, Hanbidge AE, Redston M, Lockwood GA, Gallinger S. Multi-detector row helical CT in preoperative assessment of small (< or = 1.5 cm) liver metastases: is thinner collimation better? Radiology. 2002 Oct;225(1):137-42. Principal Author.
244. Crook J, Milosevic M, Catton P, Yeung I, Haycocks T, Tran T, Catton C, Mclean M, Panzarella T, Haider MA. Interobserver variation in postimplant computed tomography contouring affects quality assessment of prostate brachytherapy. Brachytherapy. 2002;1(2):66-73. Coauthor.
245. McClure MJ, Atri M, Haider MA, Murphy J. Perineural cysts presenting as complex adnexal cystic masses on transvaginal sonography. AJR Am J Roentgenol. 2001 Dec;177(6):1313-8. Co-Principal Author.
246. Koh TS, Zeman V, Darko J, Lee TY, Milosevic MF, Haider MA, Warde P, Yeung IW. The inclusion of capillary distribution in the adiabatic tissue homogeneity model of blood flow. Phys Med Biol. 2001 May;46(5):1519-38. Coauthor.
247. Haider MA, Bret PM. The role of magnetic resonance cholangiography in primary sclerosing cholangitis. J Hepatol. 2000 Oct;33(4):659-60. Principal Author.
248. Bonifacio A, Goldberg RE, Patterson BJ, Haider MA. Flow-cytometry-enhanced fine-needle aspiration biopsy of the spleen. Can Assoc Radiol J. 2000 Jun;51(3):158-62. Co-Principal Author.
249. Rappaport DC, Haider MA, Sternthal E. Spontaneous regression of intermediate-grade non-Hodgkin’s lymphoma. AJR Am J Roentgenol. 1999 Jan;172(1):131-3. Co-Principal Author.
250. Samuels T, Liu F, Yaffe M, Haider MA. Gestational breast cancer. Canadian Assoc of Radiol J. 1998 Jun;49(3):172-80. Coauthor.
251. Samuels TH, Haider MA, Kirkbride P. Poland’s syndrome: mammographic presentation. AJR Am J Roentgenol. 1996 Feb;166(2):347-8. Co-Principal Author.
252. Haider MA, Leonhardt C, Hanna SS, Tennenhouse J. The role of intraoperative ultrasonography in planning the resection of hepatic neoplasms. Can Assoc Radiol J. 1995 Apr;46(2):98-104. Principal Author.